Cholecystokinin-lnduced effects on selective attention depend on level of activation

Neuropsychobiology

Volumn 36, Issue 2, 1997, Pages 87-95

  Pietrowsky, Reinhard ^a,b   Rudolf, Sebastian ^a   Mölle, Matthias ^a   Fehm, Horst L ^a   Born, Jan ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

Author keywords

Activation; Ceruletide; Cholecystokinin; Processing negativity; Selective attention

Indexed keywords

CERULETIDE; CHOLECYSTOKININ;

ADULT; ARTICLE; CONTROLLED STUDY; EVENT RELATED POTENTIAL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SELECTIVE ATTENTION; TASK PERFORMANCE;

ADULT; ANXIETY; AROUSAL; ATTENTION; CAERULEIN; CHOLECYSTOKININ; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; ENDOCRINE GLANDS; EVENT-RELATED POTENTIALS, P300; HEMODYNAMIC PROCESSES; HUMANS; MALE; MENTAL PROCESSES; PSYCHOMOTOR PERFORMANCE;

EID: 0030749844     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119368     Document Type: Article

References (48)

1. Stacher G, Bauer H, Steinringer H: Cholecysto-kinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man, Physiol Bchav 1979;23:325-331.
2. Stacher G, Steinringer H, Schmierer G, Schneider C: Cerulctidc decreases food intake in non-obcsc man, Peptides 1982;3:607-612.
3. Pietrowsky R, Preuss S, Bom J, Pauschinger P, Fehm HL: Effects of cholecvstokinin and calcitonin on evoked brain potentials and satiety in man, Physiol Behav 1989:46:513-519.
4. Pietrowsky R, Fehm HL, Er A, Bathelt B, Bom J: Influences of the cholecvstokinin analog ce-ruletidc on human sleep and evoked potentials, Neuropsychobiology 1990;23:41-47.
5. Pietrowsky R, Schiemann C, Fehm HL, Bom J: The P2 amplitude of the auditory evoked potential is diminished by the cholecystokinin-analog ccrulclide, J Psychophysiol 1993;7:3-10.
6. Schreiber H, Stolz-Bom G, Pietrowsky R, Komhubcr HH, Fehm HL, Born J: Improved event-related potential signs of selective attention after the administration of the cholecysto-kinin analog ccruletide in healthy persons, Biol Psychiatry 1995;37:702-712.
7. Hillyard SA, Hink RF, Schwent VL, Picton TW: Electrical signs of selective attention in the human brain, Science 1973:182:177-182.
8. Hansen JC, Hillyard SA: Endogenous brain potentials associated with selective auditory attention, Elcctroencephalogr Clin Neurophysiol 1985;49:277-290.
9. Naatanen R: Processing negativity: An evoked potential reflection of selective attention, Psychol Bull 1982;92:605-640.
10. Naatanen R: Attention and Brain Functions, Hillsdale, Erlbaum, 1992.
11. Janke W, Debus G: Die Eigenschaftswdrterlistc EWL, Gottingen, Hogrefe, 1978.
12. Woestenburg JC, Kramer CJ, Orlebeke JF, Paschier J: Brain potential differences related to spatial attention in migraineurs with and without aura symptoms supports supposed differences in activation, Headache 1993:33:413-416.
13. Lorist MM, Snel J, Kok A, Mulder G: Acute effects of caffeine on selective attention and visual search processes, Psychophysiology 1996;33:354-361.
14. Kalhmann N, Rohn I, Bommer M, Wagner M, Engel RR: Triiodthyronine effects on event-related potential correlates of selective attention: in Heinze HJ, Miinte TF, Mangun GR (eds): New Developments in Event-Related Potentials, Boston, Birkhauser, 1993. pp 283-288.
15. Brickenkamp R: Test d2. Aufmerksamkeits-Bclastungs-Test, Gottingen, Hogrefe, 1978.
16. Hillyard SA: Electrophysiology of human selective attention, T rends Neurosci 1985:9:400-405.
17. Naatanen R: The role of attention in auditory infomiation processing as revealed by event-related potentials and other brain measures of cognitive function, Bchav Brain Sci 1990:13: 201-288.
18. Amsten AFT, Segal DS, Neville HJ, Hillyard SA, Janowsky DA, Judd LL, Bloom FE: Nalox-on augments elect rophysiological signs of selective attention in man, Nature 1983:304: 725-727.
19. Amsten AFT, Neville HJ, Hillyard SA, Janowsky DS, Segal DS: Naloxon increases clcc-trophysiological measures of selective information processing in humans, J Neurosci 1984:4: 2912-2919.
20. Schroger E, Eimer M: Effects of transient spatial attention on auditory event-related potentials, Neuroreport 1993;4:588-590.
21. Schroger E: Human brain potential signs of selection by location and frequency in an auditory transient attention situation, Neurosci Lett 1994:173:163-166.
22. Woldorlf MG, Hackley SA, Hillyard SA: The effects of channel-selective attention on the mismatch negativity wave elicited by deviant tones, Psychophysiology 1991:28:30-42.
23. Kapas L, Obel F Jr., Alfdldi P, Rubicsek G, Penke B, Obal F: Effects of nocturnal intraperi-loneal administration of cholecystokinin in rats: Simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature, Brain Res 1988:438:155-164.
24. Watanabe N, Sakai T, Tada K, Masuno J, Moroji T: The effects of caerulein on nocturnal sleep, Progr Ncuropsychopharmacol Biol Psychiatry 1986:10:749-754.
25. Depoortere H, Dc Saint-Hilaire Z, Nicolaidis S: Inlrapcritoneal cholecystokinin-8 induces atypical somnolence and EEG changes, Physiol Behav 1990;48:873-877.
26. Eysenck HJ: The Biological Basis of Personality, Springfield, Thomas, 1967.
27. Tecce JJ: Contingent negative variation (CNV) and psychological processes in man, Psychol Bull 1972;77:73-108.
28. Tecce JJ: A CNV rebound effect, Electrocncc-phalogrClin Neurophysio! 1979:46:546-551.
29. Tecce JJ, Savignano-Bowman J, Cole JO: Drug effects on contingent negative variation and eyeblinks: The distraction-arousal hypothesis: in Upton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress, New York, Raven Press, 1978. pp 745-748.
30. Tecce JJ, Boehncr MB, Cattanach L, Branconnier R, Cole JO: Hydergine treatment and brain functioning (CNV rebound) in Alzheimer's patients: Preliminary findings, Psycho-pharmacol Bull 1981:17:202-206.
31. Gray J: The Neurophysiology of Anxiety, Oxford, Oxford University Press, 1984.
32. Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl ST: Effects of lorazcpam on memory, attention and sedation in man, Psychopharmacology 1988:95:208-215.
33. Sanders AF: Towards a model of stress and human performance, Acta Psychol 1983:53: 61-97.
34. Dodt C, Samighausen HE, Pictrowsky R, Fehm HL, Bom J: Ccruletide improves event-related potential indicators of cognitive processing in young but not in elderly humans, J Clin Psychopharmacol 1996:16:440-445.
35. Pietrowsky R, Thiemann A, Kern W, Fehnt HL, Born J: A nose-brain pathway for psychotropic peptides: Evidence from a brain evoked potential study with cholecystokinin, Psychoneuroendocrinology 1996:21:559-571.
36. Dc Caro G, Improta G: Disappearance of cac-rulcin from circulating blood and its inactivation in vitro by tissue homogenalcs and blood of dogs and cats, Arch Int Pharmacodyn 1972; 197:166-174.
37. Bom J, Unseld U, Pictrowsky R, Bickel U, Voigt K, Fehm HL: Time course of ACTH 4-10 cITccts on human attention, Neuroendocrinology 1990:52:169-174.
38. Born J, Kern W, Fehm-Wolfsdorf G, Fehm HL: Cortisol effects on attentional processes in man as indicated by event-related potentials, Psychophysiology 1987:24:286-292.
39. Van der Kooy D: Area postrema: Site where cholecystokinin acts to decrease food intake, Brain Res 1984;295:345-347.
40. Carter DA, Lightman SL: A role for the area postrcma in mediating cholecystokinin-stimu-latcd oxytocin secretion, Brain Res 1987;435: 327-330.
41. Willis GL, Hansky J, Smith GC: Ventricular, paraventricular and circumventricular structures involved in peptide-induced satiety, Regul Pept 1984;9:87-99.
42. Crawley JN, Schwaber JS: Nucleus tractus soli-tarius lesions block the behavioral actions of cholecystokinin, Peptides 1983;4:743-747.
43. Branchcreau P, Champagnat J, Roques BP, Denavit-Saubie M: CCK modulates inhibitory synaptic transmission in the solitary complex through CCK-B sites, Neuroreport 1992:3: 909-912.
44. Crawley JN: Cholecystokinin modulates dopamine-mediated behaviors, Ann NY Acad Sci 1994;713:138-142.
45. Shapiro RE, Miselis RR: The central neural connections of the area postrcma in the rat, J Comp Neurol 1985:234:344-364.
46. Crawley JN: Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat nicsolimbic pathway, J Neurosci 1992;12:3380-3391.
47. Graham WC, Hill DR, Woodruff GN, Sam-brook MA, Crossman AR: Reduction of ['-'IJBolton Hunter CCK8 and [HjMK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-in-duced hemi-parkinsonism in the monkey, Neurosci Lett 1991:131:129-134.
48. Octh KM, Lewis DA: Cholecystokinin-and dopamine-containing mesencephalic neurons provide distinct projections to monkey pre-frontal cortex, Neurosci Lett 1992:145:87-92.